CTOs on the Move

TigerConnect

www.tigerconnect.com

 
TigerConnect is healthcare`s most widely adopted communication platform – uniquely modernizing care collaboration among doctors, nurses, patients, and care teams. TigerConnect is the only solution that combines a consumer-like user experience for text, video, and voice communication with the serious security, privacy, and clinical workflow requirements that today`s healthcare organizations demand. TigerConnect accelerates productivity, reduces costs, and improves patient outcomes. Trusted by more than 5,000 healthcare organizations, TigerConnect maintains 99.99% verifiable uptime and processes more than 10 million messages each day.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Tim Goodwin
 Chief Technology Officer Profile

Funding

TigerConnect raised $22.5M on 09/05/2018
TigerConnect raised $300M on 01/11/2022

Similar Companies

Busse Hospital Disposables

Busse Hospital Disposables is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mr Grab Bar Inc

Mr Grab Bar Inc is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VetnCare

VetnCare is a collective of AAHA accredited animal hospitals located in Northern California that believe the highest standard of veterinary care comes from veterinarian owned hospitals, led by their clinical teams.

Elite CEU

Elite CEU, Inc. is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scynexis

SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.